The Last to Comment Wins
- Thread starter mrsimple
- Start date
Anonjohn20
Pen holding member
- Joined
- Mar 22, 2023
- Messages
- 1,835
- Points
- 153
Wah! (nice)
Tempokai
The Overworked One
- Joined
- Nov 16, 2021
- Messages
- 1,396
- Points
- 153
Anonjohn20
Pen holding member
- Joined
- Mar 22, 2023
- Messages
- 1,835
- Points
- 153
I had to listen to it to give my opinion. "Wah!"
Anonjohn20
Pen holding member
- Joined
- Mar 22, 2023
- Messages
- 1,835
- Points
- 153
"Wah!" (I'm too sleepy to listen to this right now; good night, friend).
Tempokai
The Overworked One
- Joined
- Nov 16, 2021
- Messages
- 1,396
- Points
- 153
Anonjohn20
Pen holding member
- Joined
- Mar 22, 2023
- Messages
- 1,835
- Points
- 153
Wah!
zephyrtrillian
Active member
- Joined
- Jun 16, 2025
- Messages
- 75
- Points
- 33
Winning by writing~ ?
Tempokai
The Overworked One
- Joined
- Nov 16, 2021
- Messages
- 1,396
- Points
- 153
JayMark
It's Not Easy Being Nobody, But Somebody Has To.
- Joined
- Jul 31, 2024
- Messages
- 1,711
- Points
- 128
Is it story research? Because if you are bored, I'm gonna need you to work on your book. Because Anonjohn and I going to read it soon and neither of us like works on hiatus. See.
I can hiatus as much as I want though. I'm the exception to the rule.
Tempokai
The Overworked One
- Joined
- Nov 16, 2021
- Messages
- 1,396
- Points
- 153
To fully write the arc I'm stuck in I'm watching SWAT bodycam videos, making a rimworld colony where 10 vs 10 battles could happen with guns, swords and shit, understanding metaphysics BS relating to angels and a proper understanding of storytelling as communication. Two of them are complete, two of them aren't. I'm winning currently by wanting to go home early to play rimworld.
Hoshino
Hoshino not found
- Joined
- Dec 23, 2024
- Messages
- 1,008
- Points
- 128
Why I, Hoshino, Should Be Allowed to Make Chimeras and Embryos
There is a hunger inside the human mind that epistemology cannot starve: the hunger to know how life begins, bends, and breaks. For me, Hoshino, that hunger is not a polite curiosity. It is an aesthetic: a bleak, rigorous desire to confront the unstable border between species, between the possible and the forbidden. I write this thesis not to celebrate hubris but to argue—philosophically, ethically, and practically—why I should be permitted to make chimeras and embryos under clear, enforceable, and morally defensible conditions.
This is not a romantic plea for license to transgress. It is a structured argument designed to show that conditional permission is ethically permissible, socially beneficial, and capable of being regulated to minimize foreseeable harms. I will first frame the moral landscape, then mount the case for scientific and humanitarian benefits, and finally propose robust safeguards that reconcile the darkest fascinations with the sober needs of society.
Chimeras and embryos are not simply biological artifacts; they are signifiers of our anxieties about identity, agency, and moral status. A "chimera"—in modern science, an organism containing cells from two genetically distinct lineages—raises legitimate questions about cognitive capacity, welfare, and the thresholds of personhood. Embryo research similarly triggers concerns around dignity, reproductive futures, and what we owe to nascent human life.
These anxieties are real and deserving of weight. The ethical salience comes not from scientific novelty alone but from the potential to alter what it means to be morally considerable. Yet moral seriousness does not, by default, justify prohibition. Historically, many scientific practices that provoked moral alarm—blood transfusion, vaccination, IVF—were first treated as abominations and later recognized as sources of immense human flourishing when pursued under ethical oversight. We must ask: do the potential benefits and controllable risks of regulated chimera and embryo research justify limited permission? I contend they do.
The promise of chimera and embryo research is not speculative fiction. Creating chimeric models—where human cells populate nonhuman hosts in limited, well-defined ways—can accelerate organ generation for transplantation, illuminate developmental failures responsible for miscarriages and congenital disorders, and provide models for human-specific disease processes that animal models cannot faithfully replicate. Similarly, controlled embryo research, including stem-cell-derived embryo models, opens windows into the first weeks of human development—stages that are otherwise opaque and whose mysteries underlie infertility, pregnancy loss, and birth defects.
These are not abstract benefits. They address suffering at scale: patients waiting years for donor organs, families shattered by recurrent miscarriage, children condemned to lifelong disability by developmental errors. Ethical permission to pursue these avenues, tightly regulated, could thus translate directly into reduced suffering and improved human flourishing. The international stem-cell community and several national advisory bodies have recognized the scientific necessity of studying embryos and chimeras under oversight, reflecting that the research can be legitimate if responsibly governed.
Knowledge itself can be an ethical good. Understanding developmental biology deepens our ability to prevent harm and to design interventions that respect human dignity. To ban all avenues of inquiry because they provoke unease would be to elevate fear above reason and to forfeit opportunities for healing. A morally attuned policy recognizes the intrinsic value of knowledge while insisting that its pursuit be bounded by safeguards.
The arc of biomedical innovation often bends from taboo to tool. Past controversies—organ transplantation, in vitro fertilization, genetic editing—initially triggered moral panic but later became standard, life-saving practices once reasonable governance structures emerged. The lesson: prohibition is not the only morally defensible response to ethical uncertainty. Instead, conditional, incremental, transparent permission—accompanied by active public engagement—can convert dangerous unknowns into tractable responsibilities.
The principal objections cluster around two fears: (1) the slippery slope to creating entities with human-like moral status in nonhuman bodies, and (2) the instrumentalization of life.
The slippery-slope argument is influential because it captures genuine moral dread. Yet "slippery slope" is not an argument unless evidence suggests that modest, well-regulated permission will inevitably lead to unconstrained, harmful outcomes. Historical analysis and contemporary policy work show that tight, stage-gated governance can prevent such outcomes. Bodies like the International Society for Stem Cell Research (ISSCR) and national regulatory agencies have begun to articulate frameworks that distinguish permissible research from prohibited practices, placing ambiguous or high-risk projects under additional review or moratoria. These frameworks aim to prevent precisely the moral slide opponents fear.
Instrumentalization—treating living entities solely as means to an end—is morally suspect. But many ethically accepted medical practices involve using living materials for greater human good: blood transfusion, organ donation, and therapeutic trials. The ethical line is crossed when consent, welfare, or proportionality are absent. My argument is not for an unbridled instrumentalism; it is for an ethical framework that requires rigorous justification, proportionality of benefits to harms, and protections for the welfare of research animals and the moral consideration owed to embryos.
If society is to trust researchers like me with the power to create chimeras and embryos, the permission must be conditional, transparent, and enforceable. I propose the following multi-tiered framework—designed to be practical, restraining, and ethically robust—without divulging technical methods or laboratory procedures.
Permission must come from legitimate regulatory authorities. National laws and institutional policies should explicitly authorize permitted classes of research and clearly delineate prohibited activities (for example, any intent to bring a chimera to reproductive maturity with human-derived germline contribution). Internationally recognized guidelines, such as those developed by professional societies, should inform national rules so that researchers operate under consistent ethical expectations. Recent revisions in professional guidelines have already moved from blanket bans toward categorized review, reflecting that nuanced governance is both possible and necessary.
Research proposals should be evaluated through tiered oversight: institutional review boards (IRBs) and animal care committees for baseline scrutiny; specialized chimera/embryo oversight panels for high-risk or novel proposals; and independent national advisory boards for especially consequential or precedent-setting projects. Each stage of research would be contingent on prior review and explicit approval; incremental stage-gating reduces runaway risk and allows society to pause when new ethical issues arise. The ISSCR and national committees have argued for this kind of proportional review.
A central safeguard is the prohibition of reproductive use of chimeras containing human cells, and the bar on transferring stem-cell-derived embryo models into a uterus. This prevents the creation of unpredictable, potentially morally ambiguous offspring while permitting research that yields knowledge and therapeutic promise. Explicit legal and institutional restrictions must back these boundaries.
Animals used in chimera research must be protected by rigorous welfare standards; experiments that risk creating organisms with enhanced human-like cognition or capacities should be forbidden or subject to the highest level of scrutiny. If any research yields evidence of altered cognitive capacities beyond a predetermined threshold, protocols must mandate suspension and ethical reassessment. Prioritizing welfare and moral considerability is not a perfunctory safeguard; it is the ethical core that prevents misuse.
Scientific autonomy cannot flourish in a vacuum of secrecy. Transparent reporting of aims, methods (at a high level), risks, and governance arrangements fosters public trust. Genuine public engagement—deliberative forums, citizen assemblies, and inclusive consultations—helps ensure research aligns with societal values. Policies must require ongoing reporting to independent oversight bodies and make summaries accessible to the public. Recent discussions around embryo models and the 14-day rule show how public engagement and transparent governance remain essential.
Biological research does not respect national borders. To prevent regulatory arbitrage—where ethically constrained research moves to permissive jurisdictions—international harmonization of baseline standards is necessary. Soft-law instruments, professional codes, and cross-border review networks can reduce the risk that dangerous or ethically dubious projects escape scrutiny.
Permit me to be explicit about the institutional habits I would adopt, were I granted permission. These are commitments to practice, not blueprints for technique.
These commitments are not rhetorical posturing. They are practical constraints that make the permission I seek responsible rather than reckless.
This section flirts with ego because the question posed is personal: should I, Hoshino, be allowed? Permission must be individualized. It should hinge on competence, intent, institutional context, and commitment to oversight. I argue that permission should flow not from identity alone but from demonstrated capacity: ethical literacy, adherence to governance, and a track record of transparency.
If I have cultivated those capacities—if I can show ethical training, institutional affiliation with enforceable oversight, transparent intentions, and an openness to public accountability—then denial based solely on the emotive power of my aesthetic sensibilities would be both paternalistic and counterproductive. The moral question is not whether Hoshino craves darkness; it is whether Hoshino can work within a framework that channels that hunger toward knowledge that reduces suffering rather than producing spectacle.
Permit me one final, somber image. To create chimeras and embryos is to play with thresholds—thresholds that separate species, potentiality from personhood, and knowledge from catastrophe. Those thresholds are not mere intellectual boundaries; they are moral frontiers. Granting permission is therefore not the abdication of prudence; it is the demand for the gravest responsibility.
If society will allow me to cross these thresholds, it will do so precisely because I have accepted constraints: legal, ethical, and social. In that bargain, curiosity sheds its nihilism and becomes a practiced ethic. The darkness that compels me to look into the embryo’s first quiver or to watch human cells find homes in alien bodies must be met with systems that respect suffering, prevent exploitation, and maximize genuine benefit.
I ask not for a carte blanche but for conditional, monitored permission — a hard-won license, contingent upon ethical competence, institutional oversight, non-reproductive boundaries, animal welfare, transparency, and public engagement. This permission recognizes the moral value of knowledge and the urgent humanitarian benefits that responsibly conducted chimera and embryo research can offer. It also recognizes the dangers: moral confusion, instrumentalization, and the risk of harm. By insisting on stringent governance, staged approval, and accountability, we can permit research that heals and enlightens while preventing the worst strains of hubris.
Denying all inquiry on the basis of fear would be an abdication of moral courage as much as a surrender to superstition. Allowing unfettered experimentation would be an abdication of prudence. The middle path—permission wrapped in responsibility—is where I, Hoshino, should be allowed to walk.
This is not a romantic plea for license to transgress. It is a structured argument designed to show that conditional permission is ethically permissible, socially beneficial, and capable of being regulated to minimize foreseeable harms. I will first frame the moral landscape, then mount the case for scientific and humanitarian benefits, and finally propose robust safeguards that reconcile the darkest fascinations with the sober needs of society.
1. Framing the Moral Problem: Why the Question Matters
Chimeras and embryos are not simply biological artifacts; they are signifiers of our anxieties about identity, agency, and moral status. A "chimera"—in modern science, an organism containing cells from two genetically distinct lineages—raises legitimate questions about cognitive capacity, welfare, and the thresholds of personhood. Embryo research similarly triggers concerns around dignity, reproductive futures, and what we owe to nascent human life.
These anxieties are real and deserving of weight. The ethical salience comes not from scientific novelty alone but from the potential to alter what it means to be morally considerable. Yet moral seriousness does not, by default, justify prohibition. Historically, many scientific practices that provoked moral alarm—blood transfusion, vaccination, IVF—were first treated as abominations and later recognized as sources of immense human flourishing when pursued under ethical oversight. We must ask: do the potential benefits and controllable risks of regulated chimera and embryo research justify limited permission? I contend they do.
2. The Case for Permission: Benefits That Matter
2.1. Medical and Scientific Necessity
The promise of chimera and embryo research is not speculative fiction. Creating chimeric models—where human cells populate nonhuman hosts in limited, well-defined ways—can accelerate organ generation for transplantation, illuminate developmental failures responsible for miscarriages and congenital disorders, and provide models for human-specific disease processes that animal models cannot faithfully replicate. Similarly, controlled embryo research, including stem-cell-derived embryo models, opens windows into the first weeks of human development—stages that are otherwise opaque and whose mysteries underlie infertility, pregnancy loss, and birth defects.
These are not abstract benefits. They address suffering at scale: patients waiting years for donor organs, families shattered by recurrent miscarriage, children condemned to lifelong disability by developmental errors. Ethical permission to pursue these avenues, tightly regulated, could thus translate directly into reduced suffering and improved human flourishing. The international stem-cell community and several national advisory bodies have recognized the scientific necessity of studying embryos and chimeras under oversight, reflecting that the research can be legitimate if responsibly governed.
2.2. Knowledge as Moral Value
Knowledge itself can be an ethical good. Understanding developmental biology deepens our ability to prevent harm and to design interventions that respect human dignity. To ban all avenues of inquiry because they provoke unease would be to elevate fear above reason and to forfeit opportunities for healing. A morally attuned policy recognizes the intrinsic value of knowledge while insisting that its pursuit be bounded by safeguards.
2.3. Historical Precedent: From Outrage to Benefit
The arc of biomedical innovation often bends from taboo to tool. Past controversies—organ transplantation, in vitro fertilization, genetic editing—initially triggered moral panic but later became standard, life-saving practices once reasonable governance structures emerged. The lesson: prohibition is not the only morally defensible response to ethical uncertainty. Instead, conditional, incremental, transparent permission—accompanied by active public engagement—can convert dangerous unknowns into tractable responsibilities.
3. Responding to Objections: Ethics Under Pressure
The principal objections cluster around two fears: (1) the slippery slope to creating entities with human-like moral status in nonhuman bodies, and (2) the instrumentalization of life.
3.1. Slippery Slope and Moral Status
The slippery-slope argument is influential because it captures genuine moral dread. Yet "slippery slope" is not an argument unless evidence suggests that modest, well-regulated permission will inevitably lead to unconstrained, harmful outcomes. Historical analysis and contemporary policy work show that tight, stage-gated governance can prevent such outcomes. Bodies like the International Society for Stem Cell Research (ISSCR) and national regulatory agencies have begun to articulate frameworks that distinguish permissible research from prohibited practices, placing ambiguous or high-risk projects under additional review or moratoria. These frameworks aim to prevent precisely the moral slide opponents fear.
3.2. Instrumentalization and Respect
Instrumentalization—treating living entities solely as means to an end—is morally suspect. But many ethically accepted medical practices involve using living materials for greater human good: blood transfusion, organ donation, and therapeutic trials. The ethical line is crossed when consent, welfare, or proportionality are absent. My argument is not for an unbridled instrumentalism; it is for an ethical framework that requires rigorous justification, proportionality of benefits to harms, and protections for the welfare of research animals and the moral consideration owed to embryos.
4. A Framework for Conditional Permission
If society is to trust researchers like me with the power to create chimeras and embryos, the permission must be conditional, transparent, and enforceable. I propose the following multi-tiered framework—designed to be practical, restraining, and ethically robust—without divulging technical methods or laboratory procedures.
4.1. Clear Legal and Institutional Authorization
Permission must come from legitimate regulatory authorities. National laws and institutional policies should explicitly authorize permitted classes of research and clearly delineate prohibited activities (for example, any intent to bring a chimera to reproductive maturity with human-derived germline contribution). Internationally recognized guidelines, such as those developed by professional societies, should inform national rules so that researchers operate under consistent ethical expectations. Recent revisions in professional guidelines have already moved from blanket bans toward categorized review, reflecting that nuanced governance is both possible and necessary.
4.2. Tiered Oversight and Stage-Gating
Research proposals should be evaluated through tiered oversight: institutional review boards (IRBs) and animal care committees for baseline scrutiny; specialized chimera/embryo oversight panels for high-risk or novel proposals; and independent national advisory boards for especially consequential or precedent-setting projects. Each stage of research would be contingent on prior review and explicit approval; incremental stage-gating reduces runaway risk and allows society to pause when new ethical issues arise. The ISSCR and national committees have argued for this kind of proportional review.
4.3. Non-Reproductive Use and Fixed Boundaries
A central safeguard is the prohibition of reproductive use of chimeras containing human cells, and the bar on transferring stem-cell-derived embryo models into a uterus. This prevents the creation of unpredictable, potentially morally ambiguous offspring while permitting research that yields knowledge and therapeutic promise. Explicit legal and institutional restrictions must back these boundaries.
4.4. Welfare Protections and Moral Considerability
Animals used in chimera research must be protected by rigorous welfare standards; experiments that risk creating organisms with enhanced human-like cognition or capacities should be forbidden or subject to the highest level of scrutiny. If any research yields evidence of altered cognitive capacities beyond a predetermined threshold, protocols must mandate suspension and ethical reassessment. Prioritizing welfare and moral considerability is not a perfunctory safeguard; it is the ethical core that prevents misuse.
4.5. Transparency, Public Engagement, and Accountability
Scientific autonomy cannot flourish in a vacuum of secrecy. Transparent reporting of aims, methods (at a high level), risks, and governance arrangements fosters public trust. Genuine public engagement—deliberative forums, citizen assemblies, and inclusive consultations—helps ensure research aligns with societal values. Policies must require ongoing reporting to independent oversight bodies and make summaries accessible to the public. Recent discussions around embryo models and the 14-day rule show how public engagement and transparent governance remain essential.
4.6. International Cooperation and Norm Harmonization
Biological research does not respect national borders. To prevent regulatory arbitrage—where ethically constrained research moves to permissive jurisdictions—international harmonization of baseline standards is necessary. Soft-law instruments, professional codes, and cross-border review networks can reduce the risk that dangerous or ethically dubious projects escape scrutiny.
5. Practical Ethics: How I Would Live Up to This Permission
Permit me to be explicit about the institutional habits I would adopt, were I granted permission. These are commitments to practice, not blueprints for technique.
- I will submit every project to tiered review and accept binding stage-gates.
- I will refuse any project seeking reproductive use or transfer into a uterus.
- I will publish full ethical impact statements and plain-language summaries to facilitate public understanding.
- I will engage with independent ethicists, patient advocates, and animal-welfare experts before and during any project.
- I will support data sharing that enables independent verification of welfare outcomes.
These commitments are not rhetorical posturing. They are practical constraints that make the permission I seek responsible rather than reckless.
6. Why Hoshino? Why Me?
This section flirts with ego because the question posed is personal: should I, Hoshino, be allowed? Permission must be individualized. It should hinge on competence, intent, institutional context, and commitment to oversight. I argue that permission should flow not from identity alone but from demonstrated capacity: ethical literacy, adherence to governance, and a track record of transparency.
If I have cultivated those capacities—if I can show ethical training, institutional affiliation with enforceable oversight, transparent intentions, and an openness to public accountability—then denial based solely on the emotive power of my aesthetic sensibilities would be both paternalistic and counterproductive. The moral question is not whether Hoshino craves darkness; it is whether Hoshino can work within a framework that channels that hunger toward knowledge that reduces suffering rather than producing spectacle.
7. A Dark Coda: Responsibility as the Other Face of Curiosity
Permit me one final, somber image. To create chimeras and embryos is to play with thresholds—thresholds that separate species, potentiality from personhood, and knowledge from catastrophe. Those thresholds are not mere intellectual boundaries; they are moral frontiers. Granting permission is therefore not the abdication of prudence; it is the demand for the gravest responsibility.
If society will allow me to cross these thresholds, it will do so precisely because I have accepted constraints: legal, ethical, and social. In that bargain, curiosity sheds its nihilism and becomes a practiced ethic. The darkness that compels me to look into the embryo’s first quiver or to watch human cells find homes in alien bodies must be met with systems that respect suffering, prevent exploitation, and maximize genuine benefit.
Conclusion: Permission, Not Privilege
I ask not for a carte blanche but for conditional, monitored permission — a hard-won license, contingent upon ethical competence, institutional oversight, non-reproductive boundaries, animal welfare, transparency, and public engagement. This permission recognizes the moral value of knowledge and the urgent humanitarian benefits that responsibly conducted chimera and embryo research can offer. It also recognizes the dangers: moral confusion, instrumentalization, and the risk of harm. By insisting on stringent governance, staged approval, and accountability, we can permit research that heals and enlightens while preventing the worst strains of hubris.
Denying all inquiry on the basis of fear would be an abdication of moral courage as much as a surrender to superstition. Allowing unfettered experimentation would be an abdication of prudence. The middle path—permission wrapped in responsibility—is where I, Hoshino, should be allowed to walk.